Resmed (RMD) Change in Accured Expenses (2009 - 2026)

Resmed (RMD) has 18 years of Change in Accured Expenses data on file, last reported at $103.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 64.65% year-over-year to $103.9 million; the trailing twelve-month figure through Mar 2026 stood at $171.2 million (up 4.52% YoY), and the FY2025 full-year result was $91.0 million, down 25.49% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $103.9 million, up from $10.6 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $122.0 million in Q2 2024 and bottomed at -$34.4 million in Q4 2023.
• The 5-year median for Change in Accured Expenses is $10.6 million (2025), against an average of $25.0 million.
• Peak annual rise in Change in Accured Expenses reached 36862.42% in 2024, while the deepest fall reached 2399.02% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$17.3 million in 2022, then slumped by 99.02% to -$34.4 million in 2023, then jumped by 112.28% to $4.2 million in 2024, then soared by 152.25% to $10.6 million in 2025, then surged by 875.82% to $103.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $103.9 million (Q1 2026), $10.6 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison